<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="DW, Walker AS, Matthews PC. 2020. Metagenomic Nanopore sequencing of" exact="influenza" post="virus direct from clinical respiratory samples. J Clin Microbiol"/>
 <result pre="viral sequencing offers the potential for a diagnostic test for" exact="influenza" post="virus which also provides insights on transmission, evolution, and"/>
 <result pre="viral sequencing offers the potential for a diagnostic test for" exact="influenza" post="virus which also provides insights on transmission, evolution, and"/>
 <result pre="sequencing method to metagenomic sequencing of respiratory samples. We generated" exact="influenza" post="virus reads down to a limit of detection of"/>
 <result pre="strong relationship between the viral titer and the proportion of" exact="influenza" post="virus reads (P = 4.7 × 10−5). Applying our methods to clinical throat"/>
 <result pre="(P = 4.7 × 10−5). Applying our methods to clinical throat swabs, we generated" exact="influenza" post="virus reads for 27/27 samples with mid-to-high viral titers"/>
 <result pre="30 to 40). No false-positive reads were generated from 10" exact="influenza" post="virus-negative samples. Thus, Nanopore sequencing operated with 83% sensitivity"/>
 <result pre="influenced by increased host and bacterial reads. However, at high" exact="influenza" post="virus titers, we were able to reconstruct &amp;gt;99% complete"/>
 <result pre="to be used in the diagnosis and genetic analysis of" exact="influenza" post="virus and other respiratory viruses. Keywords influenza Nanopore metagenomic"/>
 <result pre="genetic analysis of influenza virus and other respiratory viruses. Keywords" exact="influenza" post="Nanopore metagenomic diagnosis epidemiology sequencing DNA sequencing diagnostics metagenomics"/>
 <result pre="WHO list of &quot;ten threats to global health�? (7). Seasonal" exact="influenza" post="causes an estimated 650,000 deaths globally each year, and"/>
 <result pre="older adults, infants, young children, pregnant women, those with underlying" exact="lung disease," post="and the immunocompromised (9). The burden of disease disproportionately"/>
 <result pre="neuraminidase inhibitors (NAI) (9). Currently, most clinical diagnostic tests for" exact="influenza" post="virus depend on detecting viral antigen or on PCR"/>
 <result pre="nonquantitative (binary) diagnostic result, and the data routinely generated for" exact="influenza" post="diagnosis have limited capacity to inform insights into epidemiological"/>
 <result pre="application of Oxford Nanopore Technologies (ONT) sequencing to generate full-length" exact="influenza" post="virus sequences from clinical respiratory samples can address these"/>
 <result pre="range of viruses (20, 22–24). To date, Nanopore sequencing of" exact="influenza" post="virus has been reported using high-titer virus from an"/>
 <result pre="using targeted enrichment by either hybridization of cDNA (26) or" exact="influenza" post="virus-specific PCR amplification (27). We therefore aimed to optimize"/>
 <result pre="We therefore aimed to optimize a metagenomic protocol for detecting" exact="influenza" post="viruses directly from clinical samples using Nanopore sequencing. We"/>
 <result pre="(Illumina) sequencing, using clinical samples from hospital patients during an" exact="influenza" post="season and samples from a controlled laboratory infection in"/>
 <result pre="a PCR-based test using the GeneXpert assay (Cepheid) to detect" exact="influenza" post="A and B viruses and respiratory syncytial virus (RSV)."/>
 <result pre="were generated by the GeneXpert assay, and we used the" exact="influenza" post="virus CT value to estimate the viral titers in"/>
 <result pre="to show processing protocol through clinical and research pipelines for" exact="influenza" post="diagnosis. (A) Clinical sample collection (orange), clinical diagnostic testing"/>
 <result pre="and processing of sequence data (purple). (B) Outline of pooled" exact="influenza" post="virus-positive samples into an influenza virus-negative background to generate"/>
 <result pre="(purple). (B) Outline of pooled influenza virus-positive samples into an" exact="influenza" post="virus-negative background to generate various titers of influenza virus"/>
 <result pre="into an influenza virus-negative background to generate various titers of" exact="influenza" post="virus (from 0 to 106 genome copies/ml), undertaken in"/>
 <result pre="titer of Hazara virus control at 104 genome copies/ml. FluA," exact="influenza" post="A virus. For methodological assessment, we focused on four"/>
 <result pre="pooled 19 throat swab samples that had tested positive for" exact="influenza" post="A virus in the clinical diagnostic laboratory to provide"/>
 <result pre="pools of throat swab samples that had tested negative for" exact="influenza" post="virus (consisting of 24, 38, and 38 individual samples)"/>
 <result pre="swabs and 5 nasal swabs) that had tested positive for" exact="influenza" post="A or B virus, selected to represent the widest"/>
 <result pre="samples, we selected 10 individual throat swab samples that were" exact="influenza" post="virus negative. Quantification of viral RNA in samples. We"/>
 <result pre="We quantified viral titers in Hazara virus stocks and pooled" exact="influenza" post="A virus-positive throat swabs by quantitative reverse transcription-PCR (qRT-PCR),"/>
 <result pre="consensus sequences were subjected to a BLAST search against an" exact="influenza" post="virus sequence database that included &amp;gt;2,000 H1N1 and H3N2"/>
 <result pre="virus sequence database that included &amp;gt;2,000 H1N1 and H3N2 seasonal" exact="influenza" post="virus sequences between 2018 and 2019 and were downloaded"/>
 <result pre="SAMtools v1.5 (34) and Pysam (https://github.com/pysam-developers/pysam). The subtype of the" exact="influenza" post="A virus derived from each clinical sample was determined"/>
 <result pre="time course, from 3 days prior to first exposure with" exact="influenza" post="H1N1pdm09 virus and at days 1, 2, 3, and"/>
 <result pre="protocol is shown in Fig. 1A. We first sequenced five" exact="influenza" post="A virus-positive and five influenza virus-negative throat swabs, each"/>
 <result pre="1A. We first sequenced five influenza A virus-positive and five" exact="influenza" post="virus-negative throat swabs, each spiked with Hazara virus control"/>
 <result pre="extraction from the supernatant. We used a pooled set of" exact="influenza" post="A virus-positive samples (concentration, 106 genome copies/ml) to provide"/>
 <result pre="virus control spiked in at 104 genome copies/ml. Enrichment for" exact="influenza" post="virus and Hazara virus was similar for filtration versus"/>
 <result pre="original protocol, using triplicate extractions from the pooled set of" exact="influenza" post="A virus-positive samples demonstrated no significant loss in performance"/>
 <result pre="retrieval of Hazara virus by Nanopore sequencing. Starting with an" exact="influenza" post="A virus-positive sample pool (106 genome copies/ml), we made"/>
 <result pre="copies/ml), we made three volumetric dilution series using three independent" exact="influenza" post="virus-negative pools (Fig. 1B). The total quantity of cDNA"/>
 <result pre="throat swab samples. FIG 2 Characteristics of three pools of" exact="influenza" post="virus-negative throat swabs and Nanopore sequence results following spiking"/>
 <result pre="virus-negative throat swabs and Nanopore sequence results following spiking with" exact="influenza" post="A virus. (A) Total concentration of cDNA produced per"/>
 <result pre="undiluted material, represented by the black bars. Samples diluted to" exact="influenza" post="virus titers of 104, 103, and 102 contain more"/>
 <result pre="generated by Nanopore sequencing of samples with different titers of" exact="influenza" post="A virus and a consistent titer of Hazara virus"/>
 <result pre="Graphs show reads per million of total reads mapping to" exact="influenza" post="A or Hazara virus genomes, across the three individual"/>
 <result pre="from all three dilution series by Nanopore sequencing, independently of" exact="influenza" post="virus titer in the sample (Fig. 2B). Sequencing from"/>
 <result pre="nonviral RNA was introduced from this high-background pool. Limit of" exact="influenza" post="virus detection by Nanopore sequencing from pooled samples. Nanopore"/>
 <result pre="samples. Nanopore sequencing of the triplicate SISPA preparations of the" exact="influenza" post="A virus-positive pool produced mean ± standard deviation of"/>
 <result pre="standard deviation of 5.3 × 104 ± 3.6 × 104 RPM mapping to the" exact="influenza" post="A virus genome (Fig. 2B). Across the dilution series,"/>
 <result pre="genome (Fig. 2B). Across the dilution series, the proportion of" exact="influenza" post="virus reads was strongly associated with influenza virus titer"/>
 <result pre="the proportion of influenza virus reads was strongly associated with" exact="influenza" post="virus titer (P value = 4.7 × 10−5) but was also"/>
 <result pre="Hazara virus control. Sequencing the negative controls (pools with no" exact="influenza" post="virus spike) generated no reads mapping to influenza virus."/>
 <result pre="with no influenza virus spike) generated no reads mapping to" exact="influenza" post="virus. At influenza virus titers of &amp;lt;103 copies/ml, influenza"/>
 <result pre="virus spike) generated no reads mapping to influenza virus. At" exact="influenza" post="virus titers of &amp;lt;103 copies/ml, influenza virus reads were"/>
 <result pre="to influenza virus. At influenza virus titers of &amp;lt;103 copies/ml," exact="influenza" post="virus reads were inconsistently detected across the samples (Fig."/>
 <result pre="that the limit of detection is between 102 and 103" exact="influenza" post="virus copies/ml. Retrieval and reconstruction of complete influenza virus"/>
 <result pre="and 103 influenza virus copies/ml. Retrieval and reconstruction of complete" exact="influenza" post="virus genomes from pooled/spiked samples. For the Hazara virus"/>
 <result pre="in all samples (Fig. 3A). At 104 genome copies/ml of" exact="influenza" post="virus, a mean 1× coverage per segment was 90.3%"/>
 <result pre="in the high-background pool 3 to 5.7% (Fig. 3A). At" exact="influenza" post="virus titers of &amp;lt;104 copies/ml, coverage was highly varied"/>
 <result pre="correct subtyping as H3N2 (Table 1). FIG 3 Coverage of" exact="influenza" post="virus and Hazara virus genome segments achieved by Nanopore"/>
 <result pre="pooled samples (A) Data from three dilution series of pooled" exact="influenza" post="virus-positive samples, diluted with three separate negative-sample pools to"/>
 <result pre="with three separate negative-sample pools to generate different titers of" exact="influenza" post="virus. Each individual dilution was spiked with Hazara virus"/>
 <result pre="at 1× depth is shown for each of the eight" exact="influenza" post="virus genome segments (encoding PB2 [polymerase subunit 2], PB1"/>
 <result pre="of all three genome segments. (B) Representative coverage plots of" exact="influenza" post="A virus genome segments from the dilution series 1"/>
 <result pre="genome segments from the dilution series 1 sample at 104" exact="influenza" post="virus copies per ml. TABLE 1 Summary of results"/>
 <result pre="Nanopore sequencing based on pooled samples with various titers of" exact="influenza" post="A virus and a consistent titer of Hazara virus"/>
 <result pre="copies/ml) Dilution pool no. Total no. of reads No. of" exact="influenza" post="A virus reads (reads per million) Influenza A virus"/>
 <result pre="from individual clinical samples. Having demonstrated our ability to retrieve" exact="influenza" post="virus sequences from pooled influenza virus-positive material diluted with"/>
 <result pre="demonstrated our ability to retrieve influenza virus sequences from pooled" exact="influenza" post="virus-positive material diluted with negative samples, we next applied"/>
 <result pre="methods to individual anonymized clinical samples, with 40 samples testing" exact="influenza" post="virus positive and 10 samples testing influenza virus negative"/>
 <result pre="40 samples testing influenza virus positive and 10 samples testing" exact="influenza" post="virus negative in the clinical diagnostic laboratory. Data yield"/>
 <result pre="(median, 3.8 × 105 reads) (Table S1). Reads mapping to either the" exact="influenza" post="A or B virus genome were present in all"/>
 <result pre="274,955 reads). At a CT of &amp;gt;30, 6/13 samples generated" exact="influenza" post="virus reads (range, 6 to 92,057 reads) (difference between"/>
 <result pre="P &amp;lt; 0.0001; Fig. 4). The highest CT value at which any" exact="influenza" post="virus reads were detected was 36.8 (sample 37; 17"/>
 <result pre="reads were detected was 36.8 (sample 37; 17 reads of" exact="influenza" post="A virus). No reads classified as influenza virus were"/>
 <result pre="17 reads of influenza A virus). No reads classified as" exact="influenza" post="virus were obtained from sequencing the 10 GeneXpert assay-negative"/>
 <result pre="CT value and both the reads per sample classified as" exact="influenza" post="virus (R2 = 0.60) and the number of influenza"/>
 <result pre="as influenza virus (R2 = 0.60) and the number of" exact="influenza" post="virus reads per million reads (R2 = 0.62) (Fig."/>
 <result pre="generated (at 10× minimum depth) covered over 90% of the" exact="influenza" post="virus genome for 17 samples, with another two generating"/>
 <result pre="CT value of a sample from which &amp;gt;90% of an" exact="influenza" post="virus genome sequence was generated was 27.5 (Fig. S4)."/>
 <result pre="was 27.5 (Fig. S4). FIG 4 Total and proportion of" exact="influenza" post="virus reads derived by Nanopore sequencing of individual samples"/>
 <result pre="laboratory. Left, correlation between CT value and total number of" exact="influenza" post="virus reads generated. R2 = 0.604, P = 2.47e−08."/>
 <result pre="= 2.47e−08. Right, correlation between CT value and number of" exact="influenza" post="virus reads per million reads. R2 = 0.623, P"/>
 <result pre="no detectable Hazara virus reads, two with high numbers of" exact="influenza" post="virus reads (for sample 1, CT of 13.5 and"/>
 <result pre="virus reads (for sample 1, CT of 13.5 and 1.5 × 105" exact="influenza" post="B virus reads, and for sample 6, CT of"/>
 <result pre="reads, and for sample 6, CT of 18.4 and 1.5 × 104" exact="influenza" post="A virus reads) acting to dilute the control signal."/>
 <result pre="the control signal. The other two samples contained no detectable" exact="influenza" post="virus reads (for sample 34, CT of 35.9, and"/>
 <result pre="(for sample 34, CT of 35.9, and for sample 46," exact="influenza" post="virus negative). The lack of control detection therefore indicates"/>
 <result pre="platform. The proportions of reads generated that mapped to the" exact="influenza" post="virus genome were similar between the two sequencing technologies"/>
 <result pre="sequences, as expected within one geographic setting in a single" exact="influenza" post="season. FIG 5 Phylogenetic trees of consensus influenza virus"/>
 <result pre="a single influenza season. FIG 5 Phylogenetic trees of consensus" exact="influenza" post="virus HA gene derived by Nanopore and Illumina sequencing."/>
 <result pre="109 reads mapping to human coronavirus in addition to &amp;gt;1.5 × 104" exact="influenza" post="A virus reads, suggesting coinfection. We also derived &amp;gt;4.0 × 104"/>
 <result pre="We also derived &amp;gt;4.0 × 104 reads from human metapneumovirus from an" exact="influenza" post="virus-negative sample, providing a nearly complete genome (99.8% coverage)"/>
 <result pre="reproducibility of our methods across a time course model of" exact="influenza" post="A virus infection (three ferrets swabbed preinfection [day −3]"/>
 <result pre="days 1, 2, 3, and 5 following laboratory infection with" exact="influenza" post="A virus). The proportion of viral reads present at"/>
 <result pre="same cDNA (Table S2). FIG 6 Time course experiment showing" exact="influenza" post="A virus infection in three laboratory ferrets. Infection was"/>
 <result pre="proportion of total Nanopore reads (linear scale) (B) mapping to" exact="influenza" post="A virus from metagenomic sequencing of ferret nasal washes"/>
 <result pre="metagenomic sequencing of ferret nasal washes taken before and after" exact="influenza" post="virus challenge. DISCUSSION To our knowledge, this is the"/>
 <result pre="applying metagenomic Nanopore sequencing directly to respiratory samples to detect" exact="influenza" post="virus and generate influenza virus sequences. The approach demonstrates"/>
 <result pre="directly to respiratory samples to detect influenza virus and generate" exact="influenza" post="virus sequences. The approach demonstrates excellent specificity. Sensitivity varies"/>
 <result pre="to be further optimized and validated to improve sensitivity for" exact="influenza" post="virus, identify other RNA viruses, detect drug resistance mutations,"/>
 <result pre="demonstrating the ability of metagenomics to produce sufficient data for" exact="influenza" post="virus diagnostics and genome characterization, while also detecting and"/>
 <result pre="Society of America (IDSA) guidelines (9) recommend nasal/nasopharyngeal specimens for" exact="influenza" post="diagnosis, but throat swabs are easier to collect in"/>
 <result pre="virus; however, half of these contained a high titer of" exact="influenza" post="virus, so only 4% were true sensitivity failures. This"/>
 <result pre="Nanopore reads confirms semiquantitative output. Using samples from the ferret" exact="influenza" post="virus model, collected under standardized laboratory conditions, we demonstrated"/>
 <result pre="clinical diagnostics to further assess sensitivity and specificity, and using" exact="influenza" post="virus sequence data to investigate transmission events. Identifying instances"/>
 <result pre="the method is robust for the identification of commonly circulating" exact="influenza" post="virus strains in human populations, but further investigation is"/>
 <result pre="strains. Comparison with existing/alternative approaches. The current standard assay for" exact="influenza" post="diagnosis employed within the large tertiary referral teaching hospital"/>
 <result pre="study was performed is the GeneXpert assay (Cepheid), which detects" exact="influenza" post="A and B viruses and respiratory syncytial virus (RSV)."/>
 <result pre="purchasing 48 flow cells together. The cost of the current" exact="influenza" post="A/B and RSV GeneXpert test is ∼£56, and the"/>
 <result pre="approaches to generate sequence data include amplicon-based sequencing of the" exact="influenza" post="virus genome (51, 52). However, this approach detects only"/>
 <result pre="Illumina sequencing instead of Nanopore sequencing for metagenomic sequencing of" exact="influenza" post="virus (53) provides the current gold standard of sequence"/>
 <result pre="further work is needed, our methods show promise for generating" exact="influenza" post="virus sequences directly from respiratory samples. The &quot;pathogen-agnostic�? metagenomic"/>
 <result pre="doi:10.1038/s41572-018-0002-y.29955068 2.JosephU, SuYCF, VijaykrishnaD, SmithG2017The ecology and adaptive evolution of" exact="influenza" post="A interspecies transmission. Influenza Other Respir Viruses11:74–84. doi:10.1111/irv.12412.27426214 3.HumphreysM2018The"/>
 <result pre="influenza A interspecies transmission. Influenza Other Respir Viruses11:74–84. doi:10.1111/irv.12412.27426214 3.HumphreysM2018The" exact="influenza" post="of 1918: evolutionary perspectives in a historical context. Evol"/>
 <result pre="GuanY, RambautA2009Origins and evolutionary genomics of the 2009 swine-origin H1N1" exact="influenza" post="A epidemic. Nature459:1122–1125. doi:10.1038/nature08182.19516283 5.SuttonTC2018The pandemic threat of emerging"/>
 <result pre="Nature459:1122–1125. doi:10.1038/nature08182.19516283 5.SuttonTC2018The pandemic threat of emerging H5 and H7" exact="avian influenza" post="viruses. Viruses10:E461. doi:10.3390/v10090461.30154345 6.XiangD, PuZ, LuoT, GuoF, LiX, ShenX,"/>
 <result pre="doi:10.1038/nature08182.19516283 5.SuttonTC2018The pandemic threat of emerging H5 and H7 avian" exact="influenza" post="viruses. Viruses10:E461. doi:10.3390/v10090461.30154345 6.XiangD, PuZ, LuoT, GuoF, LiX, ShenX,"/>
 <result pre="LuoT, GuoF, LiX, ShenX, IrwinDM, MurphyRW, LiaoM, ShenY2018Evolutionary dynamics of" exact="avian influenza" post="A H7N9 virus across five waves in mainland China,"/>
 <result pre="GuoF, LiX, ShenX, IrwinDM, MurphyRW, LiaoM, ShenY2018Evolutionary dynamics of avian" exact="influenza" post="A H7N9 virus across five waves in mainland China,"/>
 <result pre="GosticKM, PompeiS, BedfordT, �?ukszaM, NeherRA, GrenfellBT, LässigM, McCauleyJW2018Predictive modeling of" exact="influenza" post="shows the promise of applied evolutionary biology. Trends Microbiol26:102–118."/>
 <result pre="Microbiol26:102–118. doi:10.1016/j.tim.2017.09.004.29097090 12.BlancoN, EisenbergMC, StillwellT, FoxmanB2016What transmission precautions best control" exact="influenza" post="spread in a hospital?Am J Epidemiol183:1045–1054. doi:10.1093/aje/kwv293.27188950 13.SansoneM, WimanÅ,"/>
 <result pre="BohlinL, AnderssonL-M, WestinJ, NordénR2019Molecular characterization of a nosocomial outbreak of" exact="influenza" post="B virus in an acute care hospital setting. J"/>
 <result pre="ThomsonRBJr, KaulK, DasS2019Clinical impact of rapid point-of-care polymerase chain reaction" exact="influenza" post="testing in an urgent care setting: a single center"/>
 <result pre="PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of" exact="influenza" post="virus infection. Clin Microbiol Infect25:1032–1037. doi:10.1016/j.cmi.2018.12.017.30583060 18.VotintsevaAA, BradleyP, PankhurstL,"/>
 <result pre="WyllieDH, WalkerAS, PetoTEA, CrookDW, IqbalZ2017Same-day diagnostic and surveillance data for" exact="tuberculosis" post="via whole-genome sequencing of direct respiratory samples. J Clin"/>
 <result pre="JiaX-J, WangH-H, FuX-F, JiJ-M, HeP-Y, ChenL-X, LuoJ-Y, ChenZ-W2016Dynamic quantification of" exact="avian influenza" post="H7N9(A) virus in a human infection during clinical treatment"/>
 <result pre="WangH-H, FuX-F, JiJ-M, HeP-Y, ChenL-X, LuoJ-Y, ChenZ-W2016Dynamic quantification of avian" exact="influenza" post="H7N9(A) virus in a human infection during clinical treatment"/>
 <result pre="Nanopore and Illumina sequencing for recovering whole genome sequences of" exact="chikungunya" post="and dengue viruses directly from clinical samples. Euro Surveill23:pii=1800228https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2018.23.50.1800228."/>
 <result pre="BarnesE, MatthewsPC2018Illumina and Nanopore methods for whole genome sequencing of" exact="hepatitis" post="B virus (HBV). bioRxivhttps://www.biorxiv.org/content/biorxiv/suppl/2018/11/14/470633.DC1/470633-1.pdf. 25.KellerMW, Rambo-MartinBL, WilsonMM, RidenourCA, ShepardSS,"/>
 <result pre="NeuhausEB, DuganVG, WentworthDE, BarnesJR2018Direct RNA sequencing of the coding complete" exact="influenza" post="A virus genome. Sci Rep8:14408. doi:10.1038/s41598-018-32615-8.30258076 26.EckertSE, ChanJ-M, HounietD,"/>
 <result pre="JangY, NeuhausEB, Todd DavisC, BowmanAS, WentworthDE, BarnesJR2019Mitigating pandemic risk with" exact="influenza" post="A virus field surveillance at a swine-human interface. bioRxivhttps://www.biorxiv.org/content/10.1101/585588v1."/>
 <result pre="DowallS, PlankJ, NewmanE, BarclayWS, DimmockNJ, EastonAJ, HallisB, SilmanNJ, CarrollMW2014Low dose" exact="influenza" post="virus challenge in the ferret leads to increased virus"/>
 <result pre="DeitrichJ, KlemE, ScheuermannRH2012Influenza research database: an integrated bioinformatics resource for" exact="influenza" post="research and surveillance. Influenza Other Respir Viruses6:404–416. doi:10.1111/j.1750-2659.2011.00331.x.22260278 34.LiH,"/>
 <result pre="AladinF, BrownKE2015Assessment of the utility of whole genome sequencing of" exact="measles" post="virus in the characterisation of outbreaks. PLoS One10:e0143081. doi:10.1371/journal.pone.0143081.26569100"/>
 <result pre="bioRxivhttps://www.biorxiv.org/node/147782.full. 45.MeinelDM, HeinzingerS, EberleU, AckermannN, SchönbergerK, SingA2018Whole genome sequencing identifies" exact="influenza" post="A H3N2 transmission and offers superior resolution to classical"/>
 <result pre="NelsonMI, ViboudC, TaubenbergerJK, HolmesEC2008The genomic and epidemiological dynamics of human" exact="influenza" post="A virus. Nature453:615–619. doi:10.1038/nature06945.18418375 47.ThompsonCP, LourençoJ, WaltersAA, ObolskiU, EdmansM,"/>
 <result pre="GilbertSC, GuptaS2018A naturally protective epitope of limited variability as an" exact="influenza" post="vaccine target. Nat Commun9:3859. doi:10.1038/s41467-018-06228-8.30242149 48.KafetzopoulouLE, PullanST, LemeyP, SuchardMA,"/>
 <result pre="OkamotoM, NishiyamaY, TarumotoN, MitsutakeK, MurakamiT, MaesakiS, MaedaT2018Whole genome sequencing of" exact="influenza" post="A and B viruses with the MinION sequencer in"/>
 <result pre="doi:10.3389/fmicb.2018.02748.30483243 52.WangJ, MooreNE, DengY-M, EcclesDA, HallRJ2015MinION Nanopore sequencing of an" exact="influenza" post="genome. Front Microbiol6:766. doi:10.3389/fmicb.2015.00766.26347715 53.GreningerAL, ChenEC, SittlerT, ScheinermanA, RoubinianN,"/>
 <result pre="AriasCF, HackettJJr, SchochetmanG, MillerS, TangP, ChiuCY2010A metagenomic analysis of pandemic" exact="influenza" post="A (2009 H1N1) infection in patients from North America."/>
</results>
